News & Analysis on Clinical Trial Services & Contract Research And Development
Nventa Biopharmaceuticals hopes that the enhanced durability of its new Poly IC-Poly arginine (Poly-ICR) adjuvant will help it capture a significant share of the therapeutic and prophylactic vaccine markets.
Slovenian drugmaker Krka has paid just under $1.6m (€1m) for 7.5 per cent stakes in two Chinese drug and chemicals firms, namely Zhejiang Menovo Pharmaceuticals and Anhui Menovo Pharmaceuticals.
European pharmaceutical manufacturers stepped up calls for a blanket ban on repackaging of pharmaceuticals last week, suggesting that this would be the single most effective way to seal the supply chain for counterfeiting drugs.
Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving PPD, PRA International, SpineMark and Pacific Biometrics.